<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02295579</url>
  </required_header>
  <id_info>
    <org_study_id>24580-53750</org_study_id>
    <nct_id>NCT02295579</nct_id>
  </id_info>
  <brief_title>Will Vaginal Colonization of Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida</brief_title>
  <official_title>Vaginal Colonization After Treatment With Lactobacillus in Women With BV or Candida Will That Increase the Cure Rate After Treatment With Clindamycin for BV and Flucnazole for Candida</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skaraborg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skaraborg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      From the earlier studies the investigators have treated women with bacterial vaginosis and
      cronic vulvovaginal candida. The investigators have then treated them with laktobacilli 10
      days for 2 month. The investigators will continue to follow them and investigate if treatment
      with lactobacilli every week for 6 month will increase cure rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical diagnosis of bacterial vaginosis using air dried smears combined with Hay/Ison
      classification. Test of cure every month or every menstrual cycle using self taken smears.
      The cure will be if the woman are in group 1 according to Hay/Ison classification. This will
      also allow us to use molecular diagnosis of BV to test cure and compare this with hay/Ison.

      Test of cure for candida patiens are no visibel candida on wet smear and free of symtoms of
      candida.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>cure rate</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>colonization of lactobacilli</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lactobacillus (EcoVag)</intervention_name>
    <description>Probiotic human lactobacillus (L. gasseri and L rahmnosus)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        women with vaginal discharge with either bacterial vaginosis or candida infection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of bacterial vaginosis according to Hay/Ison or with candida diagnosed with
             wet smear.

        Exclusion Criteria:

          -  Women with chlamydia infection, Pregnancy, Herpes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per-Göran Larsson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ob/Gyn Skaraborgs hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Per-Göran B Larsson, professor</last_name>
    <phone>+46500431000</phone>
    <email>p-g.larsson@vgregion.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karin Breding, dr</last_name>
    <phone>+46500431000</phone>
    <email>karin.breding@vgregion.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Ob/Gyn, Skaraborgshospital Skövde</name>
      <address>
        <city>Skövde</city>
        <zip>541 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per-Göran B Larsson, professor</last_name>
      <phone>+46500431000</phone>
      <email>p-g.larsson@vgregion.se</email>
    </contact>
    <contact_backup>
      <last_name>Karin Breding, dr</last_name>
      <phone>+46500431000</phone>
      <email>karin.breding@vgregion.se</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kvinnokliniken</name>
      <address>
        <city>Skövde</city>
        <zip>54185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <results_reference>
    <citation>Larsson PG, Brandsborg E, Forsum U, Pendharkar S, Andersen KK, Nasic S, Hammarström L, Marcotte H. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis. 2011 Aug 19;11:223. doi: 10.1186/1471-2334-11-223.</citation>
    <PMID>21854593</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>November 20, 2014</last_update_submitted>
  <last_update_submitted_qc>November 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Skaraborg Hospital</investigator_affiliation>
    <investigator_full_name>Per-Goran Larsson</investigator_full_name>
    <investigator_title>Professor Consultat</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

